Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-086744

Options or other derivatives

  • Chief Financial Officer acquired 54,439 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ruffo Frank Chief Financial Officer 2015-12-18 Grant or award · Stock option (right to buy) +49,439 49,439 D
Ruffo Frank Chief Financial Officer 2015-12-18 Grant or award · Restricted stock units +5,000 5,000 D
Loading xslF345X03/doc4.xml…